XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $531,000 | -39.2% | 216,882 | +1.0% | 0.00% | – |
| Q2 2021 | $874,000 | -75.3% | 214,682 | -72.6% | 0.00% | – |
| Q1 2021 | $3,538,000 | -6.4% | 784,539 | +2.1% | 0.00% | – |
| Q4 2020 | $3,779,000 | -5.7% | 768,079 | +13.7% | 0.00% | – |
| Q3 2020 | $4,006,000 | +143.1% | 675,559 | +9.1% | 0.00% | – |
| Q2 2020 | $1,648,000 | +55.9% | 619,398 | +14.3% | 0.00% | – |
| Q1 2020 | $1,057,000 | -70.0% | 542,031 | +8.3% | 0.00% | – |
| Q4 2019 | $3,528,000 | -23.1% | 500,401 | +7.3% | 0.00% | – |
| Q3 2019 | $4,585,000 | +0.5% | 466,451 | +17.0% | 0.00% | – |
| Q2 2019 | $4,560,000 | +110.9% | 398,631 | +85.1% | 0.00% | – |
| Q1 2019 | $2,162,000 | +28.8% | 215,346 | +118.2% | 0.00% | – |
| Q4 2018 | $1,678,000 | +51.7% | 98,714 | +56.9% | 0.00% | – |
| Q3 2018 | $1,106,000 | – | 62,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|